About Cyanotech Corp. 
Cyanotech Corp.
Pharmaceuticals & Biotechnology
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company's products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health. The Company cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived. The Company produces its algae in Hawaii and manufactures the finished products in Hawaii and California.
Company Coordinates 
Company Details
73-4460 Queen Kaahumanu Hwy Ste 102 , KAILUA KONA HI : 96740-2637
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 2 Schemes (1.12%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Michael Davis
Independent Chairman of the Board
Dr. Gerald Cysewski
Chief Executive Officer, Executive Vice Chairman of the Board
Ms. Nancy Katz
Independent Director
Mr. Walter Menzel
Independent Director
Mr. David Mulder
Independent Director
Mr. David Vied
Independent Director
Revenue and Profits:
Net Sales:
6 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
Pharmaceuticals & Biotechnology
USD 2 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
1.04
-36.59%
0.26






